Landmark study demonstrates safety and performance of the eShunt System in the treatment of communicating hydrocephalus CereVasc, Inc., a clinical-stage medical device company developing novel, minimally invasive treatments for neurological diseases, today announced the completion of enrollment in its ETCHES 1 Study of the eShunt® System for the treatment of communicating hydrocephalus. The study was […]

Deal aims to accelerate connections between serious buyers and active, professionally represented listings. Transworld Business Advisors® (Transworld), the world’s largest business brokerage firm, today announced a strategic partnership with BizScout, the fastest-growing small business acquisition marketplace and data platform. Under the multi-year agreement, all active Transworld listings will be featured on the BizScout platform. This

Metallium Ltd. (ASX: MTM; OTCQX: MTMCF; OTCQX ADR: MTLMY) announced completion of a A$75 million strategic capital raise, led by U.S.-based investors with dedicated mandates focused on critical minerals, recycling technologies, and U.S. domestic processing capacity. The raise is timed to support U.S. commissioning and commercial scale-up of the company’s first commercial facility, Gator Point

Contracts Expected to Increase YY Circle HK Monthly Revenue by 700-800% New Partnerships Advance Regional Expansion Strategy and Further Diversify Revenue Streams YY Group Holding Limited (NASDAQ: YYGH) (“YY Group” or the “Company”), a global leader in on-demand workforce solutions and integrated facilities management (IFM), today announced that its Hong Kong subsidiary, YY Circle HK,

happyactually, a new evidence-based wellbeing and happiness assessment platform, officially launches today with a mission to help individuals gain scientifically grounded insights into their emotional and life satisfaction levels. Built on a research aligned Seven Pillars Model, happyactually offers a multi-phase happiness survey, personalized guidance, and actionable recommendations designed to help people improve wellbeing across

— Patent protection extended through 2043 — Alzheimer’s proof-of-concept study completed — Clinical and Biomarker Outcomes Expected in Q1 2026 NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) (“NeuroSense”), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, today announced that the United States Patent and Trademark Office has granted U.S. Patent No. 12,527,768, entitled

Jack Henry & Associates, Inc.® (Nasdaq: JKHY) announced today that it will host a live webcast of its second quarter fiscal year 2026 earnings conference call on February 4, 2026. The press release announcing second quarter fiscal 2026 earnings will be issued after market close on February 3, 2026. The live webcast, which will begin

Diabetes Guardians LLC, a physician-led public education organization, today announced the national launch of DG2001, a free, multilingual patient-education initiative designed to prevent diabetes-related foot complications and lower-extremity amputations through early recognition, patient education, and risk-stratified podiatric care. Free, multilingual public health platform emphasizes prevention, health equity, and podiatric care Recent policy actions by the

Former Cisco and Meraki executive to oversee Plume’s go-to-market strategy with a focus on deepening engagement with ISP customers and building subscriber confidence by turning intelligence into action Plume, a leader in cloud-managed Wi-Fi, security, and smart home services for Internet Service Providers (ISPs), today announced the appointment of Rebecca Stone as the company’s new

In this free webinar, gain insight into how early protocol decisions directly influence supply planning and RTSM configuration. Attendees will learn which protocol sections warrant deeper operational scrutiny and why. The featured speakers will discuss common assumptions that lead to downstream supply issues and how to avoid them. Attendees will be introduced to practical questions